#ledipasvir

Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.

Here’s what’s in store this year for new hepatitis C therapies, as well as approvals for new uses of existing treatments.

Highlights from presentations at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco.

The FDA has approved new indications for Gilead’s Harvoni: to treat hepatitis C in those with genotypes 4Ã¢€“6 of the virus and in those...

Gilead has applied to the FDA for approval of the combo tablet of Sovaldi and velpatasvir to treat those with genotypes 1 through 6 of...

The real-world cure rates offered by Sovaldi (sofosbuvir)-based hep C virus regimens have not been as good as those seen in clinical trials

Once you’ve officially rid yourself of hepatitis C, how certain can you be that the virus is gone for good?

Harvoni and the combination of Sovaldi and daclatasvir were the least likely to cause a severe reaction with the HIV regimens of a cohort of H...

Highlights from the 50th Annual Meeting of the European Association for the Study of the Liver.

Physicians argue the best choice is to get rid of hepatitis C right away. But your insurance company may not agree. How risky is it to wait?

Nine people taking Harvoni or Sovaldi and the heart medication Cordarone (amiodarone) have suffered from low heartbeats; one died of a heart a...

Researchers presented results from various studies on hepatitis C treatment and care at a medical conference in Seattle.

Twelve weeks of Harvoni yielded a 98 percent hepatitis C cure rate among those with genotype 1 of the virus who are coinfected with HIV.

The pharmacy benefit manager Express Scripts has will only reimburse for AbbVie’s hepatitis C regimen for people with genotype 1 of the virus.

Twelve weeks of Gilead Sciences’ newly approved Harvoni cured nearly all people with genotype 1 of hepatitis C who were coinfected with HIV in...

Harvoni (ledipasvir/sofosbuvir) is proving highly successful at treating hepatitis C among people coinfected with HIV and genotype 1 of hep C...